Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Linical Company

Linical Company
2005 FOUNDED
PUBLIC STATUS
801-900 EMPLOYEES
2183 STOCK SYMBOL
3 INVESTMENTS
$8.55 SHARE PRICE (As of Thursday Closing)
Description

Linical Co Ltd is a pharmaceutical company.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
TKS
Primary Office
  • 10F, Shin-Osaka Brick Building
  • 1-6-1, Miyahara Yodogawa-ku
  • Osaka, 532-0003
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Linical Company’s full profile, request a free trial.

Linical Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$8.13 - $16.18 $193M $8.74 $0.22 68.5K 22.6M

Linical Company Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 205,725 276,921 394,807 281,366
Revenue 101,130 102,040 82,209 77,117
EBITDA 9,676 14,640 18,370 20,280
Net Income 4,901 5,127 11,691 13,359
Total Assets 126,691 119,582 87,018 74,237
Total Debt 48,393 42,600 8,784 9,601
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Linical Company Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000 01-Oct-2019 0000 00000 00.000 Electronic Equipment and Instruments
00000000000 17-Apr-2018 000000000000000000 000.00 Other Healthcare Services 00000000 000000
Nuvisan CDD Holding 01-Dec-2014 Merger/Acquisition 00.000 Biotechnology 00000000 000000
To view this company’s complete investment and acquisition history, request access »

Linical Company Executive Team (2)

Name Title Board
Seat
Contact
Info
Kazuhiro Hatano Founder, President, Chief Executive Officer and Board Member
Antal Hajos Ph.D Chief Executive Officer, Europe